
Moderna Inc (NASDAQ:MRNA) shares are trading lower Tuesday following reports indicating that both the African Union and COVAX Consortium have declined to purchase the company's COVID-19 vaccine doses.
Lower-income countries are fighting distribution challenges including a lack of funds, hesitancy and supply-chain constraints. As a result, supply has increased and demand seems to be waning.